JPS61275224A - Collagenase-inhibiting agent - Google Patents
Collagenase-inhibiting agentInfo
- Publication number
- JPS61275224A JPS61275224A JP60117327A JP11732785A JPS61275224A JP S61275224 A JPS61275224 A JP S61275224A JP 60117327 A JP60117327 A JP 60117327A JP 11732785 A JP11732785 A JP 11732785A JP S61275224 A JPS61275224 A JP S61275224A
- Authority
- JP
- Japan
- Prior art keywords
- water
- collagenase
- heating
- soybean
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
東!上空机且立吐
本発明は、酵素、コラゲナーゼの作用を阻害する新規な
コラゲナーゼ阻害剤に関する。コラゲナーゼは硬蛋白の
1つであるコラーゲンを分解する酵素で、その作用の阻
害は医薬や食品の分野において有用である。ことに、本
発明のコラゲナーゼ阻害剤は歯周疾患の原因細菌の1つ
であるバクテロイデス・ジンジバリス(B acter
otdesgingival is)の産生ずるコラゲ
ナーゼ作用を強く阻害する。[Detailed description of the invention] East! TECHNICAL FIELD The present invention relates to a novel collagenase inhibitor that inhibits the action of the enzyme collagenase. Collagenase is an enzyme that decomposes collagen, which is a type of hard protein, and inhibition of its action is useful in the fields of medicine and food. In particular, the collagenase inhibitor of the present invention is effective against Bacteroides gingivalis, which is one of the causative bacteria of periodontal diseases.
It strongly inhibits the action of collagenase produced by otdesgingivalis).
発明の背景
近年、歯周疾患の原因に歯肉溝内のダラム陰性嫌気性細
菌が関与していることが明らかにされ、バクテロイデス
・ジンジバリスがこのような細菌のiつであり、その産
生ずるコラゲナーゼの作用が一因であることが判明して
いる。したがって、このコラゲナーゼの阻害は歯周疾患
の予防、治療に有用であるが、これに対する阻害剤はほ
とんど知られていない。BACKGROUND OF THE INVENTION In recent years, it has been revealed that Durum-negative anaerobic bacteria in the gingival sulcus are involved in the cause of periodontal disease. It turns out that this effect is a contributing factor. Therefore, inhibition of this collagenase is useful for the prevention and treatment of periodontal diseases, but few inhibitors are known for this purpose.
一方、本発明者らは大豆の成分について種々研究を重ね
る間に、意外にも、大豆を水中で高温加熱処理して抽出
した画分がバクテロイデス・ジンジバリスのコラゲナー
ゼを強く阻害することを見出した。On the other hand, while conducting various studies on the components of soybeans, the present inventors unexpectedly discovered that a fraction extracted by heat-treating soybeans in water at high temperatures strongly inhibits Bacteroides gingivalis collagenase.
l帆然A製
本発明は、大豆原料を、水または塩溶液中、60℃以上
の温度で加熱処理することにより抽出される新規なコラ
ゲナーゼ阻害剤を提供するしのである。公知のごとく、
大豆には、酵素、トリプシンの作用を阻害するトリプシ
ン・インヒビターが含まれているが、これはコラゲナー
ゼを阻害せず、本発明のコラゲナーゼ阻害剤とは異なる
。また、特定の理論に限定されるものではないが、加熱
処理を施さないと該阻害剤が得られないところから、加
熱処理により、大豆の成分が何らかの変化を生じて該阻
害剤を生成するものと解される。The present invention provides a novel collagenase inhibitor extracted by heating soybean raw materials at a temperature of 60° C. or higher in water or a salt solution. As is known,
Soybeans contain trypsin inhibitor, which inhibits the action of the enzyme trypsin, but it does not inhibit collagenase and is different from the collagenase inhibitor of the present invention. In addition, although not limited to any particular theory, since the inhibitor cannot be obtained without heat treatment, there is a theory that heat treatment causes some change in the components of soybeans to produce the inhibitor. It is understood that
発明の詳細
な説明のコラゲナーゼ阻害剤を得るための大豆原料とし
ては、サヤ付きまたはサヤなしの丸大豆、サヤ、脱脂大
豆などの各種の大豆またはその加工品を用いることがで
き、これらは、通常、粉砕または粉末化した状聾で使用
される。As the soybean raw material for obtaining the collagenase inhibitor described in the detailed description of the invention, various soybeans or processed products thereof such as whole soybeans with or without pods, pods, and defatted soybeans can be used. , used in crushed or powdered form.
大豆原料は水または塩溶液を抽出溶媒として抽出される
。用いる塩としては、塩化ナトリウム、塩化カリウムな
どが挙げられ、一般に0.01〜1M程度の水溶液を用
いる。溶媒のpHは特に限定するものではないが、通常
、2〜12、好ましくは、5〜9、さらに好ましくは6
〜8とする。抽出効率の観点から、一般に、これらの溶
媒は大豆原料1重量部に対してlO〜200容量部の割
合で用いられろ。Soybean raw materials are extracted using water or salt solution as an extraction solvent. Examples of the salts used include sodium chloride and potassium chloride, and generally an aqueous solution of about 0.01 to 1M is used. The pH of the solvent is not particularly limited, but is usually 2 to 12, preferably 5 to 9, more preferably 6.
~8. From the viewpoint of extraction efficiency, these solvents are generally used in a ratio of 10 to 200 parts by volume per 1 part by weight of the soybean raw material.
抽出は大豆原料と抽出溶媒を合して60℃以上に加熱し
て行なわれる。加熱温度の上限は特に限定するものでは
ないが、通常、オートクレーブによって達することので
きる温度、好ましくは、80〜+21℃の加熱で充分に
所望のコラゲナーゼ阻害剤を抽出することができる。な
お、60℃より低い温度では該阻害剤はほとんど抽出さ
れない。Extraction is performed by combining the soybean raw material and extraction solvent and heating the mixture to 60°C or higher. Although the upper limit of the heating temperature is not particularly limited, the desired collagenase inhibitor can usually be sufficiently extracted by heating at a temperature that can be reached by an autoclave, preferably 80 to +21°C. Note that the inhibitor is hardly extracted at temperatures lower than 60°C.
加熱時間は特に限定するものではなく、通常、5〜12
0分の範囲の加熱を行なうが、温度が低い程、加熱時間
は長くなる。一般に、100℃で30分程度の加熱が好
ましい。この加熱抽出操作は公知の適当な加熱抽出装置
を用いて行なうことができる。The heating time is not particularly limited, and is usually 5 to 12
Heating is performed in the range of 0 minutes, but the lower the temperature, the longer the heating time. Generally, heating at 100° C. for about 30 minutes is preferable. This heating extraction operation can be carried out using a known suitable heating extraction device.
加熱処理終了後、該阻害剤は公知の方法により単離でき
る。例えば、該阻害剤を含む水性画分を分離し、80%
飽和硫安による塩析を行ない、遠心分離する。得られた
沈殿を水に溶解し、透析膜を用いて水に対して充分透析
し、凍結乾燥すると、本発明の所望のコラゲナーゼ阻害
剤が得られる。After the heat treatment is completed, the inhibitor can be isolated by a known method. For example, the aqueous fraction containing the inhibitor is separated and 80%
Salt out with saturated ammonium sulfate and centrifuge. The desired collagenase inhibitor of the present invention can be obtained by dissolving the obtained precipitate in water, thoroughly dialyzing it against water using a dialysis membrane, and lyophilizing it.
このものは、一般に、黄色粉末状の物質で、主成分は分
子量約2万以上の蛋白質である。ポリアクリルアミド電
気泳動によると、分子量約2万付近に1本、3万付近に
2本のバンドを生じる。この物質は水に易溶で、メタノ
ール、エタノールに難溶である。クロロホルム、ベンゼ
ンには不溶である。吸湿性はほとんどなく、水溶液は安
定である。This substance is generally a yellow powdery substance, and its main component is protein with a molecular weight of about 20,000 or more. According to polyacrylamide electrophoresis, one band at a molecular weight of about 20,000 and two bands at a molecular weight of about 30,000 are generated. This substance is easily soluble in water and slightly soluble in methanol and ethanol. Insoluble in chloroform and benzene. It has almost no hygroscopicity and its aqueous solution is stable.
この黄色粉末状物質のバクテロイデス・ジンジバリスの
コラゲナーゼに対する50%阻害濃度(IC6゜)は7
7μg / m lである。The 50% inhibitory concentration (IC6°) of this yellow powder substance against Bacteroides gingivalis collagenase is 7
7 μg/ml.
本発明のコラゲナーゼ阻害剤には前記で得られた粉末を
さらに精製したものも包含する。この精製はイオン交換
法、ゲルー過法、電気泳動法などの常法に従って行なう
ことができ、例えば、DEAE−セルロース(ワットマ
ン社製)等のカラムに吸着させた後、塩化ナトリウムに
よる濃度勾配溶出を行ない、0.25〜0.3M塩化ナ
トリウムで溶出する両分を集めることにより、活性が5
倍以上増強した淡黄色粉末状の本発明の精製コラゲナー
ゼ阻害剤が得られる。The collagenase inhibitor of the present invention also includes those obtained by further purifying the powder obtained above. This purification can be carried out according to conventional methods such as ion exchange method, gel filtration method, and electrophoresis method. For example, after adsorption to a column such as DEAE-cellulose (manufactured by Whatman), concentration gradient elution with sodium chloride is performed. By collecting both fractions eluted with 0.25-0.3M sodium chloride, the activity was determined to be 5.
The purified collagenase inhibitor of the present invention in the form of a pale yellow powder is obtained which is enhanced more than twice as much.
かくして得られた本発明のコラゲナーゼ阻害剤はコラゲ
ナーゼの阻害の必要な分野に用いることができ、ことに
、バクテロイデス・ジンジバリスが産生ずるコラゲナー
ゼを強く阻害するところから、歯周疾患の予防、治療に
利用することができる。The thus obtained collagenase inhibitor of the present invention can be used in fields where inhibition of collagenase is required, and in particular, it can be used for the prevention and treatment of periodontal diseases since it strongly inhibits collagenase produced by Bacteroides gingivalis. can do.
寒敷鯉 つぎに実施例を挙げて本発明をさらに詳しく説明する。Kanjiki carp Next, the present invention will be explained in more detail with reference to Examples.
実施例1
脱脂大豆粉10gを50011ILのネジ蓋付瓶に入れ
、水500mi、を加え、100℃で30分間加熱処理
する。加熱処理完了後、室温まで冷却し、ガラス濾過器
を用いて大豆粉を1去し、シ戸液480m1を得る。こ
れに硫安269gを加えて塩析を行ない、1oooor
、p、m、で15分間遠心分離を行ない、得られた沈殿
を水50m1に懸濁させる。さらに、水で一昼夜透析し
、凍結乾燥して黄色粉末状の所望のコラゲナーゼ阻害剤
2.5gを得る。Example 1 10 g of defatted soybean flour was placed in a 50011IL bottle with a screw cap, 500 ml of water was added, and the mixture was heated at 100° C. for 30 minutes. After the heat treatment is completed, the mixture is cooled to room temperature, and the soybean flour is removed using a glass filter to obtain 480 ml of Shito liquid. Add 269g of ammonium sulfate to this and perform salting out.
, p, m for 15 minutes, and the resulting precipitate is suspended in 50 ml of water. Further, the mixture is dialyzed against water overnight and freeze-dried to obtain 2.5 g of the desired collagenase inhibitor in the form of a yellow powder.
この阻害剤の抗コラゲナーゼ活性をつぎのとおり測定し
た。The anti-collagenase activity of this inhibitor was measured as follows.
14c アセチル化コラーゲン(ラット皮膚コラーゲン
より調製)を、5mM塩化カルシウムを含有する0、0
5Mトリス−塩酸緩衝液(pH7,4)に溶解し、4%
溶液とする。この溶液0.5Jに20mMジチオトレイ
トール0.1mlおよび水あるいは検体水溶液0.2m
flを加え、35℃で3分間加温後、コラゲナーゼ溶液
0.2111fl(バクテロイデス・ジンジバリスの培
養液上清1党の1.5倍容アセトンで分画して得たフラ
ゲナ〜ゼをO,01Mトリス−塩酸緩衝液(+)H7,
4)100m、Mに溶解)を加え、35℃で反応させる
。60分後、ジオキサンIJを加えて反応を停止させ、
3000r、p。14c Acetylated collagen (prepared from rat skin collagen) was mixed with 0,0
Dissolved in 5M Tris-HCl buffer (pH 7,4), 4%
Make a solution. Add 0.1ml of 20mM dithiothreitol to 0.5J of this solution and 0.2ml of water or sample aqueous solution.
After heating at 35°C for 3 minutes, add 0.2111 fl of collagenase solution (flagenase obtained by fractionating 1 volume of Bacteroides gingivalis culture supernatant with 1.5 times the volume of acetone). Tris-HCl buffer (+) H7,
4) Add 100m (dissolved in M) and react at 35°C. After 60 minutes, dioxane IJ was added to stop the reaction.
3000r, p.
m、で20分間遠心分離して未変性のコラーゲンを沈降
させ、上清1m克の放射活性を測定する。検体水溶液を
用いた場合の放射活性をa、水を用いた場合の放射活性
をbとして、次式より阻害率(%)を算出する。The undenatured collagen is precipitated by centrifugation for 20 minutes at 500 ml of supernatant, and the radioactivity of 1 ml of supernatant is measured. The inhibition rate (%) is calculated from the following formula, where a is the radioactivity when an aqueous sample solution is used and b is the radioactivity when water is used.
この方法により、50%阻害濃度(ICio)を求め、
前記反応11mfj中の濃度として表示する。By this method, the 50% inhibitory concentration (ICio) is determined,
It is expressed as the concentration in the reaction 11mfj.
その結果、得られたコラゲナーゼ阻害剤のIC6゜は7
7.5μgであった。このものは、黄色粉末状の物質で
、主成分は分子量約2万以上の蛋白質である。本物質は
水に易溶で、メタノール、エタノールに難溶、クロロホ
ルム、ベンゼンには不溶である。吸湿性はほとんどなく
、水溶液は安定である。As a result, the IC6° of the collagenase inhibitor obtained was 7
It was 7.5 μg. This substance is a yellow powdery substance whose main component is protein with a molecular weight of about 20,000 or more. This substance is easily soluble in water, sparingly soluble in methanol and ethanol, and insoluble in chloroform and benzene. It has almost no hygroscopicity and its aqueous solution is stable.
実施例2
実施例1で得られたコラゲナーゼ阻害剤2.5gを0.
01Mトリス−塩酸を緩蕃液(M7.4)250mQに
溶解し、予め同じ溶媒で平衡させたDEAE−セルロー
ス(ワットマン社製)を充填したカラム(5x25cm
)に通し、塩化ナトリウムのθ〜0゜5M水溶液合計t
、2で濃度勾配溶出を行ない、0゜25M〜0.3M塩
化ナトリウム水溶液で溶出する画分を集め、これを水に
透析後、凍結乾燥し、所望の部分精製コラゲナーゼ阻害
剤375mgを得る。このものは、淡黄色粉末状の物質
で主成分は分子量約2万以上の蛋白質である。ポリアク
リルアミドゲル電気泳動法により、分子量約2万付近に
1本、3万付近に薄い2本のバンドが確認される。本物
質は水に易溶で、メタノール、エタノールに難溶で、エ
ーテル、クロロホルム、ベンゼンには不溶である。吸湿
性はほとんどなく、水溶液は安定である。この部分精製
阻害剤のIC5aは15.6μgであった。Example 2 2.5 g of the collagenase inhibitor obtained in Example 1 was mixed with 0.0 g of the collagenase inhibitor obtained in Example 1.
A column (5 x 25 cm) filled with DEAE-cellulose (manufactured by Whatman), which had been equilibrated with the same solvent, was prepared by dissolving 01M Tris-HCl in 250 mQ of a slow solution (M7.4).
) of θ~0°5M aqueous solution of sodium chloride, total t
, 2, and the fractions eluted with 0.25M to 0.3M sodium chloride aqueous solution are collected, dialyzed against water, and lyophilized to obtain 375 mg of the desired partially purified collagenase inhibitor. This substance is a pale yellow powdery substance whose main component is protein with a molecular weight of about 20,000 or more. By polyacrylamide gel electrophoresis, two faint bands are confirmed, one at a molecular weight of about 20,000 and one at a molecular weight of about 30,000. This substance is easily soluble in water, sparingly soluble in methanol and ethanol, and insoluble in ether, chloroform, and benzene. It has almost no hygroscopicity and its aqueous solution is stable. The IC5a of this partially purified inhibitor was 15.6 μg.
実施例3
サヤ付火大豆、サヤなし丸大豆、サヤおよび脱脂大豆の
コーヒー・ミル粉砕物ならびに脱脂大豆のパパイン消化
物、各100mgづつを、ネジ蓋付瓶に入れ、水5II
ILづつを加え、実施例1と同様に加熱抽出し、水性?
液を得る。各Y液0.05n克の抗コラゲナーゼ活性を
前記と同様に測定し、阻害率を算出した。結果を第1表
に示す。Example 3 Put 100 mg each of charred soybeans with pods, whole soybeans without pods, coffee mill pulverized products of pods and defatted soybeans, and papain digested products of defatted soybeans into a bottle with a screw cap, and add 5 II of water.
Add IL one by one, heat and extract in the same manner as in Example 1, and extract an aqueous solution.
Get the liquid. The anti-collagenase activity of 0.05n of each Y solution was measured in the same manner as above, and the inhibition rate was calculated. The results are shown in Table 1.
第1表
第1表に示すごとく、いずれの大豆原料からも所望のコ
ラゲナーゼ阻害剤を得ることができる。As shown in Table 1, the desired collagenase inhibitor can be obtained from any soybean raw material.
発明の効果
(1)加熱抽出の温度と時間の関係
脱脂大豆粉100mgを用い、実施例3と同様にして、
加熱温度と時間を種々変化させて加熱抽出を行ない、各
炉液0.05Ili、の阻害率を算出した。Effects of the invention (1) Relationship between temperature and time of heating extraction Using 100 mg of defatted soybean flour, in the same manner as in Example 3,
Heated extraction was performed while varying the heating temperature and time, and the inhibition rate of 0.05Ili of each furnace liquid was calculated.
結果を第2表に示す。The results are shown in Table 2.
第2表
第2表に示すごとく、60℃以上、好ましくは80℃以
上の温度でコラゲナーゼ阻害剤が抽出され、温度が低い
程、長い加熱時間を必要とする。As shown in Table 2, collagenase inhibitors are extracted at temperatures of 60° C. or higher, preferably 80° C. or higher, and lower temperatures require longer heating times.
(2)抽出溶媒の種類の影響
脱脂大豆粉100mgを実施例3と同様に、種々の抽出
溶媒5J、を用いて抽出し、その炉液の阻害率を算出し
た。結果を第3表に示す。(2) Effect of the type of extraction solvent 100 mg of defatted soybean flour was extracted using 5 J of various extraction solvents in the same manner as in Example 3, and the inhibition rate of the extraction solvent was calculated. The results are shown in Table 3.
第3表
第3表に示すごとく、本発明のコラゲナーゼ阻害剤は水
、塩化ナトリウム、塩化カリウム等の塩溶液でよく抽出
される。特に、pH6〜8で好適に抽出される。Table 3 As shown in Table 3, the collagenase inhibitor of the present invention is well extracted with water and salt solutions such as sodium chloride and potassium chloride. In particular, it is preferably extracted at pH 6 to 8.
(3)抗酵素スペクトル
実施例3と同様に、脱脂大豆粉から得られた水性I液各
0.05m1.づつを用い、各酵素液0.1i児に対す
る阻害活性を前記の抗コラゲナーゼ活性の測定に準じて
測定し、阻害率(%)を算出した。(3) Antienzyme spectrum Similarly to Example 3, each 0.05 ml of aqueous I solution obtained from defatted soybean flour. Using 0.1 i of each enzyme solution, the inhibitory activity against infants was measured according to the measurement of anti-collagenase activity described above, and the inhibition rate (%) was calculated.
結果を第4表に示す。The results are shown in Table 4.
第4表
第4表に示すごとく、本発明の阻害剤はバクテロイデス
・ジンジバリス由来のコラゲナーゼに対して特異的に高
い阻害作用を示す。Table 4 As shown in Table 4, the inhibitor of the present invention exhibits a high specific inhibitory effect on collagenase derived from Bacteroides gingivalis.
Claims (3)
度で加熱処理して抽出されるコラゲナーゼ阻害剤。(1) A collagenase inhibitor extracted by heating soybean raw materials at a temperature of 60° C. or higher in water or a salt solution.
項の阻害剤。(2) Said step (1) in which the heat treatment is performed at 80 to 121°C.
Inhibitor of the term.
は第(2)項の阻害剤。(3) The inhibitor according to item (1) or item (2) above, which is heated for 5 to 120 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60117327A JPS61275224A (en) | 1985-05-29 | 1985-05-29 | Collagenase-inhibiting agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60117327A JPS61275224A (en) | 1985-05-29 | 1985-05-29 | Collagenase-inhibiting agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61275224A true JPS61275224A (en) | 1986-12-05 |
Family
ID=14708994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60117327A Pending JPS61275224A (en) | 1985-05-29 | 1985-05-29 | Collagenase-inhibiting agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61275224A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04283518A (en) * | 1991-03-12 | 1992-10-08 | Kikkoman Corp | Agent for alleviating periodontosis |
FR2702147A1 (en) * | 1993-03-05 | 1994-09-09 | Celbert Sa Groupe | Inhibitor of collagenase activity and cosmetic composition containing such an inhibitor. |
US7282226B2 (en) | 2003-08-11 | 2007-10-16 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof |
SG142127A1 (en) * | 2003-09-12 | 2008-05-28 | Chu I Hung | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
WO2012043743A1 (en) * | 2010-09-30 | 2012-04-05 | 国立大学法人広島大学 | Anti-bacterial composition and use thereof |
-
1985
- 1985-05-29 JP JP60117327A patent/JPS61275224A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04283518A (en) * | 1991-03-12 | 1992-10-08 | Kikkoman Corp | Agent for alleviating periodontosis |
FR2702147A1 (en) * | 1993-03-05 | 1994-09-09 | Celbert Sa Groupe | Inhibitor of collagenase activity and cosmetic composition containing such an inhibitor. |
WO1994020541A1 (en) * | 1993-03-05 | 1994-09-15 | Groupe Celbert Sa | Collagenase activity inhibitor and cosmetic composition containing same |
US7282226B2 (en) | 2003-08-11 | 2007-10-16 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof |
SG142127A1 (en) * | 2003-09-12 | 2008-05-28 | Chu I Hung | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
WO2012043743A1 (en) * | 2010-09-30 | 2012-04-05 | 国立大学法人広島大学 | Anti-bacterial composition and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cohen et al. | A tropomyosin-like protein from human platelets | |
Smith | Purification of anti-pernicious anaemia factors from liver | |
US4793996A (en) | Method of making soybean extract inhibitor | |
EP0030812B1 (en) | A process for preparing substances having interferon inducing activity and interferon inducers | |
Tu et al. | Isolation and characterization of the toxic component of Enhydrina schistosa (common sea snake) venom | |
JP3071669B2 (en) | Antiallergic substance, method for producing the same, antiallergic agent and functional food | |
JPH06256387A (en) | New peptide, its production and hypotensive agent comprising the same as active ingredient | |
JPS61275224A (en) | Collagenase-inhibiting agent | |
WO1981001517A1 (en) | Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice | |
CN108048518B (en) | Chicken blood cell antioxidant peptide and enzymolysis preparation method thereof | |
US3905870A (en) | Purification of kallikrein | |
JPS61162184A (en) | Novel fibrinolytic enzyme an production thereof | |
SU871721A3 (en) | Method of preparing biologically active substance capable to enhance insuline secretion and to improve glucose tolerance | |
JPS62286926A (en) | Collagenase inhibitor | |
Ogura et al. | Studies on chlorophyllase of tea leaves | |
CN105037493B (en) | Tuna dark meat protein antioxidant iron chelating peptide | |
US3522229A (en) | Glycoprotein from saliva or salivary glands having gastric acid secretion inhibitory as well as anti-ulcerative activity and method of collecting the same | |
CN105002245B (en) | Preparation method of tuna dark meat protein antioxidant iron chelating peptide | |
CN117843718B (en) | Egg-derived bifunctional bioactive peptide and preparation method and application thereof | |
US2794800A (en) | Preparation of antitryptic substance from soybean | |
US9290752B2 (en) | Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts | |
Wang | Effect of phytate on isoelectric focusing of soybean whey proteins | |
JPH09309839A (en) | Platelet coagulation inhibiting material | |
JPH0429968A (en) | Chalcone compound | |
JPH02233695A (en) | Novel peptide |